ADAMTS1 and endometrium adenocarcinoma: In contrast to this latter study that reports readily detectable levels of ADAMTS1 throughout the menstrual cycle [30], in our study we found minimal immunoreactivity for ADAMTS1 in proliferative phase endometrium compared with the different grades of endometrial adenocarcinomas.